Page last updated: 2024-08-18

framycetin and daunorubicin

framycetin has been researched along with daunorubicin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Herdewijn, P; Maiti, M; Nauwelaerts, K1
Banfi, P; Gambetta, RA; Lanzi, C; Parolini, O1
Waksman, SA1

Reviews

1 review(s) available for framycetin and daunorubicin

ArticleYear
Successes and failures in the search for antibiotics.
    Advances in applied microbiology, 1969, Volume: 11

    Topics: Acremonium; Actinomycetales; Amebicides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Aspergillus; Bacillus subtilis; Cephalosporins; Chloramphenicol; Dactinomycin; Daunorubicin; Erythromycin; Escherichia coli; Fusidic Acid; Griseofulvin; Neomycin; Nystatin; Penicillins; Penicillium; Polymyxins; Pseudomonas aeruginosa; Quackery; Streptomycin; Tetracycline; Tyrothricin

1969

Other Studies

3 other study(ies) available for framycetin and daunorubicin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
    Bioorganic & medicinal chemistry letters, 2012, Feb-15, Volume: 22, Issue:4

    Topics: Aminoglycosides; Antineoplastic Agents; Base Sequence; DEAD-box RNA Helicases; Humans; MicroRNAs; Models, Biological; Molecular Sequence Data; Ribonuclease III; RNA Processing, Post-Transcriptional

2012
Lipid peroxidation, phosphoinositide turnover and protein kinase C activation in human platelets treated with anthracyclines and their complexes with Fe(III).
    Biochemical pharmacology, 1992, Apr-01, Volume: 43, Issue:7

    Topics: Blood Platelets; Daunorubicin; Diglycerides; Doxorubicin; Enzyme Activation; Ferric Compounds; Humans; Inositol Phosphates; Lipid Peroxidation; Neomycin; Phosphatidic Acids; Phosphatidylinositols; Phosphorylation; Protein Kinase C

1992